-The Indian Express After the market rates crashed to Rs 1-2 per kg, only 565 tomato growers across Haryana received the average price difference payment of Rs 2,136. Kurukshatra: Jasbir Saini shows a message on his iBall mobile phone displaying an amount of Rs 296 credited to his bank account. That’s what the 47-year-old has received as “differential price” on the distress sale of his tomato crop under the Haryana government’s Bhavantar...

  Released in May this year, a study by Save the Children has found that if you are an adolescent girl living in the country, then you are most likely to be afraid about being harassed outside your homes viz. in public places. Entitled WINGS 2018 - World of India's Girls: A study on the perception of girls’ safety in public spaces, the study shows that nearly one-third of teenage girls surveyed...

-Press release by organizers of All India Media Educators Conference-2018, dated 12th July, 2018 Jaipur: About 200 media educators, researchers and practitioners from all over India, during 3RD All India Media Educators' Conference in Jaipur releases a declaration upholding new values and needs to upgrade standards and inculcate positive values among media practitioners. Mr Kalyan Singh Kothari, Conference Secretary, while disclosing the “AIMEC-2018 Declaration” here today said that more than 200 media...

-The Hindu On India being labelled the most unsafe country in the world for women Is India merely dangerous for women or is it the most dangerous place for women? Is measuring that on the basis of people’s perception of danger and fear any less significant than on the basis of recorded statistics? In light of India’s labelling as the ‘world’s most dangerous country for women’ in a recent global poll conducted by...

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...